Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Nature.com Nawigacja wpisu Faculty Spotlight: Maryellen Flaherty-Hewitt, MD – Yale School of Medicine Baylor College of Medicine offers help unraveling rare diseases, strange symptoms – FOX 26 Houston